[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis] | Zendy

R. Patriarchi | Zendy; Antonio Di Nicola | Zendy; Orazio Grassi | Zendy; Giuseppe De Bartolomeo | Zendy

Open Access

[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]

Author(s) -

R. Patriarchi,

Antonio Di Nicola,

Orazio Grassi,

Giuseppe De Bartolomeo

Publication year - 2015

Publication title -

clinical management issues

Language(s) - English

Resource type - Journals

eISSN - 2283-3137

pISSN - 1973-4832

DOI - 10.7175/cmi.v9i4.1218

Subject(s) - medicine , tenofovir , chronic hepatitis , cohort , population , hepatitis b virus , hepatitis b , virology , virus , human immunodeficiency virus (hiv) , environmental health

Inmates are a population at risk for hepatitis B virus infection. It affects about 2% of Italian prisoners, while the prevalence in the Molise region seems to be higher, accounting for around 4% of the inmates.The Authors report their experience in a penitentiary in the management of chronic hepatitis B with tenofovir. In particular, 10 male patients affected by HBV-related chronic hepatitis naïves to treatment confined in the prisons of the Molise region were treated with tenofovir 245 mg/die. The results show a satisfactory response, excellent tolerance, and no interruptions.[Article in Italian

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research